The Claim
USF1 gene variants usf1s1 C>T and usf1s2 G>A are associated with increased catecholamine-induced lipolysis in adipocytes in vitro and enhanced insulin-mediated suppression of lipolysis in vivo in humans.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Specific variations in the USF1 gene are linked to higher fat breakdown in response to stress hormones in fat cells grown in the lab, and also to greater reduction of fat breakdown when insulin is present in humans.
See the scientific wording
The USF1 gene variants usf1s1 C>T and usf1s2 G>A are associated with increased in vitro catecholamine-induced lipolysis in adipocytes, as previously demonstrated, and this study extends those findings to show a parallel association with enhanced insulin-mediated suppression of lipolysis in vivo in humans.
People with certain versions of the USF1 gene have a stronger response to insulin in their fat cells. Insulin tells the fat cells to stop breaking down fat, and in these people, that signal works better because the gene makes more of a protein that controls fat breakdown. This means less fat is released into the blood when insulin is present.
What the research says
1 studyThis study found that people with certain versions of the USF1 gene have a stronger ability to stop fat breakdown when insulin is present, which matches the claim. It builds on earlier lab findings by showing this same gene effect works in real human bodies during insulin activity.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.